Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic

Toshiaki Takahashi1, Shinya Kikuchi, Shinichi Katada

  • 1School of Health Sciences, Faculty of Medicine, Niigata University, 1-757 Asahimachi, Niigata 951-8122, Japan.

Human Molecular Genetics
|October 20, 2007
PubMed

Insights

Soluble polyglutamine (polyQ) oligomers, not inclusion bodies, are toxic in living cells. Their formation is length-dependent and drives neurodegeneration in polyQ disorders.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Expanded polyglutamine (polyQ) repeats are implicated in neurodegenerative diseases.
  • The precise cytotoxic structures, particularly soluble oligomers versus inclusion bodies (IBs), remain unclear in living cells.

Purpose of the Study:

  • To investigate the cytotoxicity of soluble polyQ oligomers in living cells.
  • To differentiate and quantify soluble oligomers, monomers, and IBs within single cells.

Main Methods:

  • Utilized fluorescence resonance energy transfer (FRET) confocal microscopy to detect polyQ structures.
  • Distinguished soluble oligomers from monomers and IBs in real-time within living cells.
  • Performed survival assays on neuronally differentiated cells.

Main Results:

  • FRET signals confirmed the parallel or head-to-tail beta-sheet structure of soluble polyQ oligomers.
  • PolyQ oligomers were demonstrated to be soluble and formed in a length-dependent manner before IB formation.
  • Cells harboring soluble polyQ oligomers exhibited faster cell death compared to those with monomers or IBs.

Conclusions:

  • Soluble polyQ oligomers, rather than IBs, are the primary cytotoxic species in polyQ neurodegenerative disorders.
  • Length-dependent oligomer formation is a critical mechanism driving neurodegeneration in these diseases.